Endothelin-1 in patients with coronary heart disease undergoing cardiac catheterization

Department of Cardiology, Centre Hospitalier Universitaire Pitie-Salpetriere, Paris, France.

OBJECTIVES. This study examined the possible association between endothelin and coronary atherosclerosis and evaluated the synthesis and release of endothelin in the presence of various stimuli that occur during cardiac catheterization. BACKGROUND. Circulating endothelin has been reported to be increased in diffuse atherosclerosis and acute myocardial infarction. However, the relation between coronary artery disease and endothelin release remains unclear. METHODS. We measured the plasma and urinary concentrations of endothelin immunoreactivity in 45 patients and 10 healthy control subjects. RESULTS. In group IA (n = 9), simultaneous blood sampling in the coronary sinus and femoral artery during coronary angioplasty of the left anterior descending coronary artery demonstrated no immediate changes in plasma immunoreactive endothelin-1 (ir-ET-1) levels. In 11 patients in group IB undergoing coronary angioplasty of a major artery, we did not detect changes in peripheral plasma concentrations of ir-ET-1 within 24 h, but urinary ir-ET-1 levels increased from 9.2 +/- 2.3 to 18.6 +/- 4.9 pg/mg of creatinine a few hours after coronary angioplasty (mean +/- SEM, p < 0.05). This increase in urinary endothelin excretion persisted 24 h later. Group II patients (n = 12) had coronary angiography without coronary angioplasty. Levels of both plasma and urinary ir-ET-1 did not change during the 24-h follow-up period. There was no relation between the severity of coronary atherosclerosis and the plasma or urinary concentrations of ir-ET-1. Systolic aortic pressure correlated with basal urinary excretion of endothelin (r = 0.54, p = 0.03, n = 15). In group III (n = 13), levels of ir-ET-1 in patients undergoing right heart catheterization without angiography did not differ from those in the control group. CONCLUSIONS. The presence or the severity, or both, of coronary atherosclerosis is not associated with a detectable increase in endothelin release. The diagnostic procedures of catheterization do not modify endothelin concentrations in plasma and urine. Vascular stretch or injury, or both, during coronary angioplasty increases urinary ir-ET-1 levels a few hours after the procedure. This increase persists for at least 24 h but is not detectable by brief sampling of peripheral or coronary sinus blood.

This article has been cited by other articles:

				Z. Alioglu, A. Orem, I. Bulbul, C. Boz, M. Ozmenoglu, and B. Vanizor Evaluation of Plasma Endothelin-1 Levels in Patients with Cerebral Infarction Angiology, January 1, 2002; 53(1): 77 - 82. [Abstract] [PDF]

				W. R. Huckle, M. D. Drag, W. R. Acker, M. Powers, R. C. McFall, D. J. Holder, T. F. Walsh, R. S. Schwartz, W. J. Greenlee, and R. G. Johnson Jr Effects of L-749,329, an ETA/ETB Endothelin Receptor Antagonist, in a Porcine Coronary Artery Injury Model of Vascular Restenosis Circulation, April 10, 2001; 103(14): 1899 - 1905. [Abstract] [Full Text] [PDF]

				A. C. Sharma, B. G. Fogelson, S. I. Nawas, W. T. Vigneswaran, A. D. Sam II, K. J. Alden, J. L. Ferguson, and W. R. Law Elevated coronary endothelin-1 but not Nitric Oxide in diabetics during CABG Ann. Thorac. Surg., June 1, 1999; 67(6): 1659 - 1663. [Abstract] [Full Text] [PDF]

				U. Wilbert-Lampen, C. Seliger, T. Zilker, and R. M. Arendt Cocaine Increases the Endothelial Release of Immunoreactive Endothelin and Its Concentrations in Human Plasma and Urine : Reversal by Coincubation With {sigma}-Receptor Antagonists Circulation, August 4, 1998; 98(5): 385 - 390. [Abstract] [Full Text] [PDF]

				G. Montalescot, F. Philippe, A. Ankri, E. Vicaut, E. Bearez, J. E. Poulard, D. Carrie, D. Flammang, A. Dutoit, A. Carayon, et al. Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease : Beneficial Effects of Enoxaparin Circulation, July 28, 1998; 98(4): 294 - 299. [Abstract] [Full Text] [PDF]

				D. Hasdai, D. R. Holmes, K. N. Garratt, W. D. Edwards, and A. Lerman Mechanical Pressure and Stretch Release Endothelin-1 From Human Atherosclerotic Coronary Arteries In Vivo Circulation, January 21, 1997; 95(2): 357 - 362. [Abstract] [Full Text]